(Q37810414)

23 August 2017

Opioid therapy for osteoarthritis and chronic low back pain (English)

1 reference

23 August 2017

0 references

0 references

0 references

Roy D Altman

1

1 reference

PubMed ID

21084785

23 August 2017

Howard S Smith

series ordinal

2

1 reference

PubMed ID

21084785

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

23 August 2017

Postgraduate Medicine

1 reference

23 August 2017

122

1 reference

23 August 2017

6

1 reference

23 August 2017

87-97

1 reference

Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study

23 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Osteoarthritis of the hip or knee: which coexisting disorders are disabling?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Population-based surveillance for acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Acetaminophen hepatotoxicity and acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Will this patient develop persistent disabling low back pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioid switching and rotation in primary care: implementation and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Pyrolytic carbon proximal interphalangeal joint arthroplasty: results with minimum two-year follow-up evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Two to five year follow-up of the LPM ceramic coated proximal interphalangeal joint arthroplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Pharmacological therapies for osteoarthritis of the hand: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Chapter 4. European guidelines for the management of chronic nonspecific low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Primary care provider concerns about management of chronic pain in community clinic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Special issues and concerns in the evaluation of older adults who have pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Urine toxicology testing in chronic pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Post-marketing experience with an opioid nasal spray for migraine: lessons for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Abuse-deterrent opioid formulations: are they a pipe dream?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Aquatic physical therapy for hip and knee osteoarthritis: results of a single-blind randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Effects of weight-bearing versus nonweight-bearing exercise on function, walking speed, and position sense in participants with knee osteoarthritis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Cost-effectiveness of interventions based on physical exercise in the treatment of various diseases: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

A long way to go: practice patterns and evidence in chronic low back pain care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Primary care treatment of knee pain--a survey in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioid therapy for nonspecific low back pain and the outcome of chronic work loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Acute opioid administration improves work-related exercise performance in patients with chronic back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Functionality and health-status benefits associated with reduction of osteoarthritis pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Functional outcomes in patients with chronic nonmalignant pain on long-term opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Effective pain relief facilitates exercise therapy : Results of a multicenter study with controlled-release oxycodone in patients with movement pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opiates should be avoided in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Increased plasma morphine metabolites in terminally ill cancer patients with delirium: an intra-individual comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Relationship between pain and opioid analgesics on the development of delirium following hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

The association between opioid analgesics and unsafe driving actions preceding fatal crashes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Investigations into the drug-drug interaction potential of tapentadol in human liver microsomes and fresh human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

The truth about pain management: the difference between a pain patient and an addicted patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Abuse liability in opioid therapy for pain treatment in patients with an addiction history

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

Assessing chronic joint pain: Lessons from a focus group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.11.2226

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.11.2226

1 reference

23 August 2017

1 reference

PubMed ID

21084785